Sugi Predict

Sugi Predict / Compounds / SCHEMBL3133236

SCHEMBL3133236

SCHEMBL3133236

CCCCCC(O)=CC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 1/20 0.54
▸ GPR84 Q9NQS5 7/20 0.52
▸ PPARG P37231 7/20 0.52
▸ PPARD Q03181 7/20 0.52
▸ PPARA Q07869 7/20 0.52
▸ HDAC11 Q96DB2 5/20 0.52
▸ TSHR P16473 4/20 0.52
▸ PTPN1 P18031 3/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ TLR2 O60603 2/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ FABP4 P15090 2/20 0.52
▸ ALOX15 P16050 2/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ SLC22A6 Q4U2R8 1/20 0.52
▸ SLC22A8 Q8TCC7 1/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ ESR1 P03372 1/20 0.52
▸ PDE4A P27815 1/20 0.52
▸ KMT2A Q03164 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3133232 1.00 AKR1B1 (0.54) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL3345555 0.98 GPR84 (0.56) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL726951 0.98 GPR84 (0.56) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL15516842 0.98 GPR84 (0.56) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL8088535 0.98 GPR84 (0.56) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL25356914 0.98 GPR84 (0.56) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL726950 0.98 GPR84 (0.56) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL3349403 0.98 GPR84 (0.56) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL8075409 0.98 GPR84 (0.56) AKR1B1GPR84PPARGPPARDPPARA
SCHEMBL5000537 0.98 GPR84 (0.56) AKR1B1GPR84PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9854799-B2 Means and methods for rhamnolipid production AMLIKA MERCANTILE PRIVATE LIMITED (IN) 2018-01-02 — — US claimed
US-20140235561-A1 MEANS AND METHODS FOR RHAMNOLIPID PRODUCTION AMLIKA MERCANTILE PRIVATE LIMITED (IN) 2014-08-21 — — US claimed
EP-2758526-A1 MEANS AND METHODS FOR RHAMNOLIPID PRODUCTION Heinrich-Heine-Universität (DE) 2014-07-30 — — EP claimed
WO-2014039940-A1 CELLS AND METHODS FOR THE PRODUCTION OF RHAMNOLIPIDS LOGOS TECHNOLOGIES LLC (US) 2014-03-13 — — WO claimed
WO-2013041670-A1 MEANS AND METHODS FOR RHAMNOLIPID PRODUCTION HEINRICH-HEINE-UNIVERSITAET (DE) 2013-03-28 — — WO claimed
EP-2573172-A1 Means and methods for rhamnolipid production Heinrich-Heine-Universität Düsseldorf (DE) 2013-03-27 — — EP claimed
WO-2010044118-A1 PRODUCTION OF BIODEGRADABLE PLASTICS FROM BRASSICA CARINATA OIL WITH HIGH CONTENT OF ERUCIC ACID AND FROM VERY LONG CHAIN FATTY ACIDS BALLISTRERI ALBERTO (IT) 2010-04-22 — — WO claimed
EP-1113076-B1 Method for producing microbial polyester CANON KK (JP) 2005-01-05 — — EP claimed
US-6492147-B2 CULTURING MICROORGANISMS, I.E. PSEUDOMONAS, IN CULTURE MEDIUM CONTAINING 1-HEXENE TO PRODUCE A POLYLACTONE; BIODEGRADABLE POLYMERS; NATURAL RECYCLING SYSTEM CANON KABUSHIKI KAISHA (JP) 2002-12-10 — — US claimed
US-20010031488-A1 Method for producing microbial polyester CANON KABUSHIKI KAISHA (JP) 2001-10-18 — — US claimed
EP-1113076-A2 Method for producing microbial polyester CANON KABUSHIKI KAISHA (JP) 2001-07-04 — — EP claimed
EP-1044278-A1 BIOSYNTHESIS OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES MONSANTO COMPANY (US) 2000-10-18 — — EP claimed
WO-1999035278-A1 BIOSYNTHESIS OF MEDIUM CHAIN LENGTH POLYHYDROXYALKANOATES MONSANTO COMPANY (US) 1999-07-15 — — WO claimed
US-9854799-B2 Means and methods for rhamnolipid production AMLIKA MERCANTILE PRIVATE LIMITED (IN) 2018-01-02 — — US disclosed
EP-2791327-B1 FOAM ADSORPTION AMLIKA MERCANTILE PRIVATE LTD (AMPL) (IN) 2017-08-30 — — EP disclosed
US-9353238-B2 Compositions including poly(hydroxyalkanoates) and graphene REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2016-05-31 — — US disclosed
US-5334698-A Pseudomonas culture product; polylactones from 3-hydroxy-alkanoates RIJKSUNIVERSITEIT TE GRONINGEN (NL) 1994-08-02 — — US disclosed
EP-0274151-B1 A process for producing polyesters by fermentation; a process for producing optically active carboxylic acids and esters; articles of manufacture comprising polyester UNIV GRONINGEN (NL) 1994-03-16 — — EP disclosed
US-5135859-A Culturing pseudomonas on substrate RIJKS UNIVERSITEIT TO GRONINGEN (NL) 1992-08-04 — — US disclosed
EP-0274151-A2 A process for producing polyesters by fermentation; a process for producing optically active carboxylic acids and esters; articles of manufacture comprising polyester Rijksuniversiteit te Groningen (NL) 1988-07-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140235561-A1 MEANS AND METHODS FOR RHAMNOLIPID PRODUCTION MRPL21, CMBL, MGLL AKR1B1 2493/4885GPR84 3386/4885PPARG 3369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.